At the 2018 Marbach Castle Drug-Drug Interaction Workshop in Germany, Dr. Brian Ogilvie, Vice President of Scientific Consulting, presented a comparison between the new US FDA and Japan PMDA as well as most recent European EMA in vitro DDI guidance documents. His presentation included an informative reference poster outlining the current FDA, EMA & PMDA guidance experimental details, equations, cut-off values, etc. for in vitro drug-drug interaction studies that is now available for download.
Learn more about:
About the Authors
Subscribe to our Newsletter
Stay up to date with our news, events and research
Do you have a question or a request for upcoming blog content?
We love to get your feedback